MORGAN STANLEY - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 27 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$482,964
-8.4%
75,228
+6.3%
0.00%
Q1 2023$526,990
+2973.4%
70,737
+1702.7%
0.00%
Q4 2022$17,147
+0.9%
3,924
+31.8%
0.00%
Q3 2022$17,000
+6.2%
2,977
+4.5%
0.00%
Q2 2022$16,000
-92.2%
2,850
-85.9%
0.00%
Q1 2022$206,000
+202.9%
20,258
+144.2%
0.00%
Q4 2021$68,000
+15.3%
8,297
+14.3%
0.00%
Q3 2021$59,000
-39.2%
7,261
-60.2%
0.00%
Q2 2021$97,00018,2270.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 131,731$508,0000.16%
SABBY MANAGEMENT, LLC 160,182$618,0000.12%
ZEKE CAPITAL ADVISORS, LLC 45,000$174,0000.01%
Freedom Investment Management, Inc. 16,339$63,0000.01%
Virtu Financial LLC 15,121$58,0000.00%
TORONTO DOMINION BANK 12$00.00%
ROYAL BANK OF CANADA 17$00.00%
UBS Group AG 632$2,0000.00%
OSAIC HOLDINGS, INC. 6,012$23,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders